The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): Imaging findings with clinical and pathological correlation

被引：66

作者：

Courcoutsakis N.A. ^{[1
,2
]}

Tatsi C. ^{[2
]}

Patronas N.J. ^{[3
]}

Lee C.-C.R. ^{[4
]}

Prassopoulos P.K. ^{[1
]}

Stratakis C.A. ^{[2
]}

机构：

[1] Department of Radiology and Medical Imaging, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis

[2] Section on Endocrinology and Genetics (SEGEN), Developmental Endocrinology Branch (DEB), National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, MD

[3] Department of Diagnostic Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD

[4] Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD

来源：

Insights into Imaging | 2013年 / 4卷 / 1期

关键词：

Carney complex; Ductal adenoma; Large-cell calcifying sertoli cell tumour; Myxoma; Osteochondromyxoma; Primary pigmented nodular adrenocortical disease; Protein kinase A; Psammomatous melanotic schwannoma; Spotty skin pigmentation;

D O I：

10.1007/s13244-012-0208-6

中图分类号：

学科分类号：

摘要：

The complex of myxomas, spotty skin pigmentation and endocrine overactivity, or Carney complex (CNC), is a familial multiple endocrine neoplasia and lentiginosis syndrome. CNC is inherited in an autosomal dominant manner and is genetically heterogeneous. Its features overlap those of McCune-Albright syndrome and other multiple endocrine neoplasia (MEN) syndromes. Spotty skin pigmentation is the major clinical manifestation of the syndrome, followed by multicentric heart myxomas, which occur at a young age and are the lethal component of the disease. Myxomas may also occur on the skin (eyelid, external ear canal and nipple) and the breast. Breast myxomas, when present, are multiple and bilateral among female CNC patients, an entity which is also described as "breast-myxomatosis" and is a characteristic feature of the syndrome. Affected CNC patients often have tumours of two or more endocrine glands, including primary pigmented nodular adrenocortical disease (PPNAD), an adrenocorticotropin hormone (ACTH)-independent cause of Cushing's syndrome, growth hormone (GH)-secreting and prolactin (PRL)-secreting pituitary adenomas, thyroid adenomas or carcinomas, testicular neoplasms (large-cell calcifying Sertoli cell tumours [LCCSCT]) and ovarian lesions (cysts and cancinomas). Additional infrequent but characteristic manifestations of CNC are psammomatous melanotic schwannomas (PMS), breast ductal adenomas (DAs) with tubular features, and osteochondromyxomas or "Carney bone tumour". Teaching Points Almost 60 % of the known CNC kindreds have a germline inactivating mutations in the PRKAR1A gene. Spotty skin pigmentation is the major clinical manifestation of CNC, followed by heart myxomas. Indicative imaging signs of PPNAD are contour abnormality and hypodense spots within the gland. Two breast tumours may present in CNC: myxoid fibroadenomas (breast myxomatosis) and ductal adenomas. Additional findings of CNC are psammomatous melanotic schwannomas (PMSs) and osteochondromyxomas. © 2013 The Author(s).

引用

页码：119 / 133

页数：14

共 48 条

[1] Carney, J.A., The complex of myxomas, spotty skin pigmentation and endocrine overactivity (1985) Medicine, 64 (4), pp. 270-283
[2] http://omimorg/, OMIM (12/10/2010) MIM number: #160980. Johns Hopkins University, Baltimore, MD. World Wide Web URL
[3] Rothenbuhler, A., Stratakis, C.A., Clinical and molecular genetics of Carney complex (2010) Best Pract Res Clin Endocrinol Metab, 24 (3), pp. 389-399
[4] Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., Stratakis, C.A., Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes (2009) J Clin Endocrinol Metab, 94 (6), pp. 2085-2091
[5] Stratakis, C.A., Kirschner, L.S., Carney, J.A., Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation (2001) J Clin Endocrinol Metab, 86 (9), pp. 4041-4046
[6] Casey, M., Mah, C., Merliss, A.D., Kirschner, L.S., Taymans, S.E., Denio, A.E., Korf, B., Basson, C.T., Identification of a novel genetic locus for familial cardiac myxomas and Carney complex (1998) Circulation, 98 (23), pp. 2560-2566
[7] Stratakis, C.A., Carney, J.A., Lin, J.P., Papanicolaou, D.A., Karl, M., Kastner, D.L., Pras, E., Chrousos, G.P., Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2 (1996) J Clin Invest, 97 (3), pp. 699-705
[8] Kirschner, L.S., Carney, J.A., Pack, S.D., Taymans, S.E., Giatzakis, C., Cho, Y.S., Cho-Chung, Y.S., Stratakis, C.A., Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex (2000) Nat Genet, 26 (1), pp. 89-92
[9] Bossis, I., Stratakis, C.A., Minireview: PRKAR1A: normal and abnormal functions (2004) Endocrinology, 145 (12), pp. 5452-5458
[10] Boikos, S.A., Stratakis, C.A., Carney complex: the first 20 years (2007) Curr Opin Oncol, 19 (1), pp. 24-29

← 1 2 3 4 5 →